The partnership is set to capitalise on Viatris' extensive global reach and expertise in the cardiovascular sector. Credit: ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...

Huel, the meal replacement maker known for powdered food and “ready to drink” shakes, has posted a surge in profits as it ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

"Metformin was associated with a lowered risk of asthma attacks by approximately 30%," the researchers found. When patients ...

Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...